Comparative study between simple and optimized liposomal dispersion of quetiapine fumarate for diffusion through nasal route

References

• Acharya SP, Pundarikakshudu K, Upadhyay P, et al. (2015). Development of phenytoin intranasal microemulsion for treatment of epilepsy. J Pharm Invest 45:375–84
   Google Scholar
• Abbott NJ, Romero IA. (1996). Transporting therapeutics across the blood brain barrier. Mol Med Today 2:106–13
   PubMedGoogle Scholar
• Afergan E, Epstein H, Dahan R, et al. (2008). Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. J Control Release 132:84–90
   PubMed Web of Science ®Google Scholar
• Alsarra IA, Hamed AY, Alanazi FK. (2008). Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation. Drug Deliv 15:313–21
   PubMed Web of Science ®Google Scholar
• Arora P, Sharma S, Gary SS. (2002). Permeability issues in nasal drug delivery. Drug Discov Today 7:967–75
   PubMed Web of Science ®Google Scholar
• Arumugam K, Subramanian GS, Mallayasamy SR, et al. (2008). A study of rivastigmine liposomes for delivery into the brain through intranasal route. Acta Pharm 58:287–97
   PubMed Web of Science ®Google Scholar
• Bamba M, Puisieux F, Marty JP, Carstensen JT. (1979). Release mechanisms in gel forming sustained release preparation. Int J Pharm 2:307–15
   Web of Science ®Google Scholar
• Brgles M, Jurasin D, Sikirić MD, et al. (2008). Entrapment of ovalbumin into liposomes-factors affecting entrapment efficiency, liposome size, and zeta potential. J Liposome Res 18:235–48
   PubMed Web of Science ®Google Scholar
• Chandaroy P, Sen A, Alexandridis S, Hui SW. (2002). Utilizing temperature-sensitive association of Pluronic F-127 with lipid bilayers to control liposome cell adhesion. Biochim Biophys Acta 1559:32–42
   PubMed Web of Science ®Google Scholar
• Ding WX, Qi XR, Fu Q, Piao HS. (2007). Pharmacokinetics and pharmacodynamics of sterylglucoside-modified liposomes for levonorgestrel delivery via nasal route. Drug Deliv 14:101–4
   PubMed Web of Science ®Google Scholar
• Ehrhardt C, Kim KJ. (2007). Drug absorption studies: in situ, in vitro and in silico models. New York, USA: Springer Science & Business Media
   Google Scholar
• Freireich EJ. (1966). Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 50:219–44
   PubMedGoogle Scholar
• Frey WH. (2002). Intranasal delivery: bypassing the blood–brain barrier to deliver therapeutic agents to the brain and spinal cord. Drug Deliv Technol 2:46–9
   Google Scholar
• Garcia EG, Andrieux K, Gilb S, Couvreur P. (2005). Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int J Pharm 298:274–92
   PubMed Web of Science ®Google Scholar
• Hamed SA, Mahmoud AA, Kamel AO, et al. (2012). Phospholipid based colloidal poloxamer–nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B: Biointerfaces 100:146–54
   PubMed Web of Science ®Google Scholar
• He L, Wang Y, Li Z, et al. (2012). Determination of entrapment efficiency and transmembrane activation energy of gefitinib liposomes. Asian J Pharm Sci 7:251–8
   Google Scholar
• Heng KY, Kei TY, Singh KJ, et al. (2014). Handbook of cosmeceutical excipients and their safeties. Cambridge, UK: Elsevier
   Google Scholar
• Hildebrandt IJ, Su H, Weber WA. (2008). Anesthesia and other considerations for in vivo imaging of small animals. ILAR J 49:17–26
   PubMed Web of Science ®Google Scholar
• Jung SH, Seong H, Cho SH, et al. (2009). Polyethylene glycolcomplexed cationic liposome for enhanced cellular uptake and anticancer activity. Int J Pharm 382:254–61
   PubMed Web of Science ®Google Scholar
• Kararli TT, Needham TE, Griffin M, et al. (1992). Oral delivery of a renin inhibitor compound using emulsion formulations. Pharm Res 9:888–93
   PubMed Web of Science ®Google Scholar
• Kumar A, Pandey AN, Jain SK. (2014). Nasal-nanotechnology: revolution for efficient therapeutics delivery. Drug Deliv. [Epub ahead of print]. doi:10.3109/10717544.2014.920431
   Web of Science ®Google Scholar
• Laouini A, Jaafar MC, Limayem BI, et al. (2012). Preparation, characterization and applications of liposomes: state of the art. J Colloid Sci Biotechnol 1:147–68
   Google Scholar
• Liu JJ, Nazzal S, Chang TS, Tsai T. (2013). Preparation and characterization of cosmeceutical liposomes loaded with avobenzone and arbutin. J Cosmet Sci 64:9–17
   PubMed Web of Science ®Google Scholar
• Lohan S, Sharma S, Murthy RR. (2015). Formulation and evaluation of solid lipid nanoparticles of QTF and Quetiapine Hemifumarate for brain delivery in rat model. Pharm Nanotechnol 1:239–47
   Google Scholar
• Michel AD, Suzuki K. (1985). Zeta potential of colloids in water and waste water. ASTM Standard D 95:4187–92
   Google Scholar
• Nivsarkar M, Pathak R, Dash RP, Misra M. (2014). Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route. Acta Pharm Sin B 4:151–60
   PubMedGoogle Scholar
• Parmar H, Bhandari A, Shah D. (2011). Recent techniques in nasal drug delivery: a review. Int J Drug Dev Res 3:99–106
   Google Scholar
• Patel RB, Patel MR, Bhatt KK, et al. (2014). Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2014.912694
   Web of Science ®Google Scholar
• Pathan SASZI, Zaidi MA, Talegaonkar S, Vohra D. (2009). CNS drug delivery systems: novel approaches, recent patents on drug delivery & formulation, vol. 3. Oak Park (IL): Bentham Science Publishers Ltd
   Google Scholar
• Patil S, Babbar A, Mathur R, et al. (2010). Mucoadhesive chitosan microspheres of carvedilol for nasal administration. J Drug Target 18:321–31
   PubMed Web of Science ®Google Scholar
• Rathod S, Deshpande SG. (2010). Design and evaluation of liposomal formulation of pilocarpine nitrate. Indian J Pharm Sci 72:155–60
   PubMed Web of Science ®Google Scholar
• Reddy SP, Satyanarayana P, Verma KK, et al. (2011). Novel reverse phase HPLC Method development and validation of Quetiapine Fumatrate in bulk and tablet dosage form. Int J Pharm Int Res 1:95–9
   Google Scholar
• Sahu D, Rana AC. (2011). Development of analytical method for quetiapine fumarate by UV spectrophotometry. IJRAP 2:588–91
   Google Scholar
• Santos HM, Lodeiro C, Martinez JLC. (2009). 1-The power of ultrasound. In: Capelo-Martínez J-L, eds. Ultrasound in chemistry: analytical applications. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA, 1–16
   Google Scholar
• Schnyder S, Krahenbuhl J, Drewe J, Huwyler S. (2005). Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects. J Drug Target 13:325–35
   PubMed Web of Science ®Google Scholar
• Senthilkumar KL, Ezhilmuthu RP, Praveen P. (2012). Preparation and characterization of nabumetone liposomes. Int J Life Sci Bt Pharm Res 1:81–6
   Google Scholar
• Shariat S, Badiee A, Jaafari MR, Mortazavi SA. (2014). Optimization of a method to prepare liposomes containing HER2/Neu-derived peptide as a vaccine delivery system for breast cancer. Iran J Pharm Res 13:15–25
   PubMed Web of Science ®Google Scholar
• Shi N, Zhang Y, Zhu C, et al. (2001). Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci USA 98:12754–9
   PubMed Web of Science ®Google Scholar
• Sweetman SC. (2007). Martindale, the complete drug reference. London: Pharmaceutical Press
   Google Scholar
• Tomoko N, Fumiyoshi I. (2005). Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int J Pharm 298:198–205
   PubMed Web of Science ®Google Scholar
• Türker S, Onur E, Özer Y. (2004). Nasal route and drug delivery systems. Pharm World Sci 26:137–42
   PubMed Web of Science ®Google Scholar
• Ugwoke MI, Verbek N, Kinget R. (2001). The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 53:3–22
   PubMed Web of Science ®Google Scholar
• Vincenzo P, Roberto M, Anna F, Sandra F. (2003). Quality control of commercial tablets containing the novel antipsychotic quetiapine. J Pharm Biomed Anal 32:1037–44
   PubMed Web of Science ®Google Scholar
• Vyas SP, Goswami SK, Singh R. (1995). Liposomes based nasal delivery system of nifedipine: development and characterization. Int J Pharm 118:23–30
   Web of Science ®Google Scholar
• Woensel M, Wauthoz N, Rosière R, et al. (2013). Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM? Cancers 5:1020–48
   PubMedGoogle Scholar
• Xie Y, Ye L, Zhang X, et al. (2005). Transport of nerve growth factor encapsulated into liposomes across the blood–brain barrier: in vitro and in vivo studies. J Control Release 105:106–19
   PubMed Web of Science ®Google Scholar